[144] Addus HomeCare Corp. SEC Filing

Rhea-AI Filing Summary

Addus HomeCare Corp. (ADUS) filing a Form 144 notifies the proposed sale of 1,571 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $180,555.03 and an approximate sale date of 08/19/2025 on NASDAQ. The filer reports total outstanding shares of 18,407,239. The shares were acquired as restricted stock in three tranches: 1,013 on 06/12/2025, 104 on 06/16/2022, and 454 on 06/15/2021. The filing contains no reported sales in the past three months and includes the standard attestation about material nonpublic information.

Insights

Financial Analyst

TL;DR: Small insider sale; negligible dilution relative to outstanding shares.

The proposed sale of 1,571 shares equals approximately 0.0085% of the reported 18,407,239 outstanding shares, indicating the transaction is immaterial to market capitalization. Aggregate value reported is $180,555.03, implying a per-share figure consistent with the stated market value. No recent sales in the past three months are reported, and acquisitions were via restricted stock grants across 2021, 2022 and 2025, which suggests these are routine equity compensation dispositions rather than a large executive exit.

Compliance Specialist

TL;DR: Filing appears procedurally complete for a Rule 144 notice with broker and acquisition details disclosed.

The form identifies the executing broker, intended exchange (NASDAQ) and provides dates and nature of acquisition (restricted stock), which align with Rule 144 disclosure elements. The signature attestation language regarding material nonpublic information is present. The filing records no aggregated sales subject to Rule 144 in the prior three months, which simplifies compliance review. No contradictions or missing mandatory fields are evident in the provided excerpts.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1571	180555.03	18407239	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2025	Restricted Stock	Issuer			1013	06/12/2025	Not Applicable
Common	06/16/2022	Restricted Stock	Issuer			104	06/16/2022	Not Applicable
Common	06/15/2021	Restricted Stock	Issuer			454	06/15/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the ADUS Form 144 propose to sell?

The notice proposes sale of 1,571 common shares of Addus HomeCare Corp.

When is the proposed sale date listed on the Form 144 for ADUS?

The approximate sale date is listed as 08/19/2025.

What is the aggregate market value of the shares in the ADUS Form 144?

Aggregate market value is reported as $180,555.03.

How many shares outstanding does ADUS report on this Form 144?

The filing reports 18,407,239 shares outstanding.

How were the shares being sold originally acquired according to the filing?

All listed shares were acquired as restricted stock on 06/15/2021, 06/16/2022, and 06/12/2025.